No Drip Severe Congestion
Pricing Report NDC 68016-309-03

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for No Drip Severe Congestion Premier Value (NDC 68016-309-03) is $0.05954 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 19, 2014.

As a provided by Chain Drug Consortium, this medication is distributed in a 1 BOTTLE, SPRAY in 1 CARTON / 30 mL in 1 BOTTLE, SPRAY configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.05954
Per ML

Effective Date
Nov 19, 2014
Data Status
As of Nov 19, 2014
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE, SPRAY in 1 CARTON / 30 mL in 1 BOTTLE, SPRAY
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.05026 to $0.05954 per ML. Over this 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0503 - $0.0595
Market Volatility
18.46% Variance
Latest Trend
7.82%
Date Unit Price Unit Source Method Rate
Nov 19, 2014 $0.05954 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 22, 2014 $0.05522 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 17, 2014 $0.05026 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 20, 2014 $0.05400 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 23, 2014 $0.05365 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 18, 2014 $0.05311 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 21, 2014 $0.05450 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 23, 2014 $0.05484 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 19, 2014 $0.05628 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 19, 2014 $0.05538 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 22, 2014 $0.05633 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 18, 2013 $0.05256 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 21, 2013 $0.05367 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026